Bosh sahifa4DX • ASX
4DMedical Ltd
0,63 $
27-sen, 19:00:00 (GMT+10) · AUD · ASX · Ogohlantirish
AksiyalarAU qimmatli qogʻozi
Yopilish kursi
0,45 $
Kunlik diapazon
0,53 $ - 0,67 $
Yillik diapazon
0,41 $ - 1,10 $
Bozor kapitalizatsiyasi
255,76 mln AUD
Oʻrtacha hajm
334,14 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
ASX
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(AUD)iyn, 2024Y/Y qiyosi
Daromad
1,48 mln1 172,70%
Joriy xarajat
12,56 mln11,42%
Sof foyda
-10,19 mln-33,78%
Sof foyda marjasi
-687,8489,49%
Har bir ulushga tushum
EBITDA
-11,09 mln-5,51%
Amaldagi soliq stavkasi
-0,01%
Jami aktivlari
Jami passivlari
(AUD)iyn, 2024Y/Y qiyosi
Naqd pul va qisqa investitsiyalar
30,61 mln-56,01%
Jami aktivlari
120,02 mln29,16%
Jami passivlari
49,09 mln128,71%
Umumiy kapital
70,93 mln
Tarqatilgan aksiyalar
410,39 mln
Narxi/balansdagi bahosi
2,62
Aktivlardan daromad
-23,28%
Kapitaldan daromad
-36,73%
Naqd pulning sof oʻzgarishi
(AUD)iyn, 2024Y/Y qiyosi
Sof foyda
-10,19 mln-33,78%
Operatsiyalardan naqd pul
-8,06 mln8,54%
Sarmoyadan naqd pul
-339,48 ming-21,29%
Moliyadan naqd pul
-233,98 ming-101,11%
Naqd pulning sof oʻzgarishi
-8,64 mln-172,48%
Boʻsh pul
-5,43 mln13,25%
Haqida
4DMedical is a medical technology company, based in Australia and the United States. 4DMedical created X-ray Velocimetry Lung Ventilation Analysis Software based on the company's proprietary XV Technology. XV Technology uses patented algorithms adapted from advanced aerodynamics research to process and enhance X-ray and Computed Tomography images. Airflow is measured throughout all regions of the lung, across all phases of the breath—providing clinicians with quantitative lung ventilation data in a report. 4DMedical has commercialized its XV Technology via a Software as a Service model, where patients are scanned using existing imaging equipment and analyzed by 4DMedical remotely. Airflow is measured throughout all regions of the lung, across all phases of the breath, delivering the capability to quantify regional lung function throughout the respiratory cycle, at every location within the lung. The lung function data is provided to clinicians and patients in a report that includes color-coded lung images. This approach enables the detection of subtle functional losses before lung structure is irreversibly effected by the disease. Wikipedia
Tashkil etilgan
2013
Xodimlar soni
131
Qidiruv
Qidiruv maydonini tozalash
Qidiruvni yopish
Google ilovalari
Asosiy menyu